Evidence map›Paper›PMID 27810884›Full record

ArticleFEMS microbiology letters2016

Enterotoxigenic Escherichia coli heat-stable toxin and heat-labile toxin toxoid fusion 3xSTaN12S-dmLT induces neutralizing anti-STa antibodies in subcutaneously immunized mice.

Rahul Nandre, Xiaosai Ruan, Qiangde Duan, Weiping Zhang

Open access · bronzeAbstract read
In one paragraph

Article in FEMS microbiology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Recent progress in enterotoxigenicInfection and immunity · 2025
    Review
  4. Article
  5. Evaluation of Multivalent EnterotoxigenicApplied and environmental microbiology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Adjuvant effect of enterotoxigenicHuman vaccines & immunotherapeutics · 2020
    Article
  12. Article
  13. Article
  14. Development of an enterotoxigenicHuman vaccines & immunotherapeutics · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Co-administered Tag-Less Toxoid Fusion 3xSTaFrontiers in microbiology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rahul Nandre
Xiaosai Ruan
Qiangde Duan
Weiping Zhang

Funding

A subunit vaccine for enterotoxigenic E. coli associated traveler's diarrheaR21AI109209 · NIAID · KANSAS STATE UNIVERSITY · PI ZHANG, WEIPING · 2014 to 2015
$413k
NIAID NIH HHS R21 AI109209
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) bacteria producing heat-stable toxin (STa) and/or heat-labile toxin (LT) are among top causes of children's diarrhea and travelers' diarrhea. Currently no vaccines are available for ETEC associated diarrhea. A major challenge in developing ETEC vaccines is the inability to stimulate protective antibodies against the key STa toxin that is potently toxic and also poorly immunogenic. A recent study suggested toxoid fusion 3xSTaN12S-dmLT, which consists of a monomer LT toxoid (LTR192G/L211A) and three copies of STa toxoid STaN12S, may represent an optimal immunogen inducing neutralizing antibodies against STa toxin [IAI 2014, 82(5):1823-32]. In this study, we immunized mice with this fusion protein following a different parenteral route and using different adjuvants to further characterize immunogenicity of this toxoid fusion. Data from this study showed that 3xSTaN12S-dmLT toxoid fusion induced neutralizing anti-STa antibodies in the mice following subcutaneous immunization, as effectively as in the mice under intraperitoneal route. Data also indicated that double mutant LT (dmLT) can be an effective adjuvant for this toxoid fusion in mice subcutaneous immunization. Results from this study affirmed that toxoid fusion 3xSTaN12S-dmLT induces neutralizing antibodies against STa toxin, suggesting this toxoid fusion is potentially a promising immunogen for ETEC vaccine development.

Indexed as

diarrheaETEC (enterotoxigenic E. coli)neutralizing antibodiestoxoid fusionvaccine

Identifiers

PMID27810884
PMCPMC10101651
OpenAlexW2548723123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.